Assignee
OSI PHARM INC
US·77 granted patents·11 pending applications·1,321 citations·filing 1992–2011
Top patents by PatentIndex Score
88 records- 0199US7534797B26,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitorsOSI PHARM INC·Filed 2005·Granted May 19, 2009·100 cites·9 claims
- 0295US7700594B2Fused bicyclic mTOR inhibitorsOSI PHARM INC·Filed 2006·Granted Apr 20, 2010·38 cites·6 claims
- 0395US6680324B2Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2001·Granted Jan 20, 2004·68 cites·37 claims
- 0495US6680322B2Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2000·Granted Jan 20, 2004·67 cites·37 claims
- 0594US6900221B1Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereofOSI PHARM INC·Filed 2000·Granted May 31, 2005·100 cites·79 claims
- 0694US6165712AMethods of transcriptionally modulating expression of viral genes and genes useful for production of proteinsOSI PHARM INC·Filed 1995·Granted Dec 26, 2000·120 cites·23 claims
- 0792US7651687B2Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitorsOSI PHARM INC·Filed 2007·Granted Jan 26, 2010·33 cites·28 claims
- 0892US7485658B2N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Feb 3, 2009·39 cites·5 claims
- 0992US7465726B2Substituted pyrrolo[2.3-B]pyridinesOSI PHARM INC·Filed 2005·Granted Dec 16, 2008·35 cites·14 claims
- 1092US6916804B2Pyrimidine A2b selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2002·Granted Jul 12, 2005·45 cites·22 claims
- 1191US7923555B2Fused bicyclic mTor inhibitorsOSI PHARM INC·Filed 2008·Granted Apr 12, 2011·15 cites·2 claims
- 1291US7087613B2Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochlorideOSI PHARM INC·Filed 2004·Granted Aug 8, 2006·47 cites·14 claims
- 1389US7820662B26,6-bicyclic ring substituted heterobicyclic protein kinase inhibitorsOSI PHARM INC·Filed 2008·Granted Oct 26, 2010·12 cites·19 claims
- 1489US7648987B2Bicyclic protein kinase inhibitorsOSI PHARM INC·Filed 2006·Granted Jan 19, 2010·17 cites·8 claims
- 1589US6800633B2Pyrrolo[2,3d]pyrimidine compositions and their useOSI PHARM INC·Filed 2000·Granted Oct 5, 2004·29 cites·16 claims
- 1689US6673802B2Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 2001·Granted Jan 6, 2004·26 cites·16 claims
- 1788US7943767B2Fused bicyclic mTOR inhibitorsOSI PHARM INC·Filed 2009·Granted May 17, 2011·9 cites·14 claims
- 1888US7504407B2Compounds specific to adenosine A1 and A3 receptors and uses thereofOSI PHARM INC·Filed 2002·Granted Mar 17, 2009·29 cites·12 claims
- 1988US7459554B2Imidazopyrazine tyrosine kinase inhibitorsOSI PHARM INC·Filed 2004·Granted Dec 2, 2008·45 cites·68 claims
- 2087US7419995B2N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole libraryOSI PHARM INC·Filed 2005·Granted Sep 2, 2008·8 cites·16 claims
- 2186US7939272B2Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitorsOSI PHARM INC·Filed 2008·Granted May 10, 2011·11 cites·10 claims
- 2286US7659274B2Unsaturated mTOR inhibitorsOSI PHARM INC·Filed 2007·Granted Feb 9, 2010·9 cites·3 claims
- 2386US6664252B24-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereofOSI PHARM INC·Filed 2000·Granted Dec 16, 2003·28 cites·34 claims
- 2485US7405210B2Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylaseOSI PHARM INC·Filed 2004·Granted Jul 29, 2008·18 cites·20 claims
- 2585US7160890B2Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 2000·Granted Jan 9, 2007·16 cites·46 claims
- 2685US6136779AMethods of specifically transcriptionally modulating the expression of gene of interestOSI PHARM INC·Filed 1997·Granted Oct 24, 2000·48 cites·40 claims
- 2783US7429574B24-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their useOSI PHARM INC·Filed 2004·Granted Sep 30, 2008·14 cites·8 claims
- 2882US7741324B2Imidazotriazines as protein kinase inhibitorsOSI PHARM INC·Filed 2005·Granted Jun 22, 2010·6 cites·12 claims
- 2982US7101893B2(2-Carboxamido)(3-amino)thiophene compoundsOSI PHARM INC·Filed 2005·Granted Sep 5, 2006·4 cites·2 claims
- 3081US7951549B2Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formationOSI PHARM INC·Filed 2009·Granted May 31, 2011·9 cites·93 claims
- 3181US6878716B1Compounds specific to adenosine A1 receptor and uses thereofOSI PHARM INC·Filed 1999·Granted Apr 12, 2005·27 cites·35 claims
- 3280US6699894B1Methods for treatment of inflammatory bowel diseaseOSI PHARM INC·Filed 2002·Granted Mar 2, 2004·13 cites·2 claims
- 3378US7115647B2Method of inhibiting neoplastic cells with indole derivativesOSI PHARM INC·Filed 2002·Granted Oct 3, 2006·6 cites·3 claims
- 3477US7816325B2Secondary binding site of dipeptidyl peptidase IV (DP IV)OSI PHARM INC·Filed 2006·Granted Oct 19, 2010·1 cites·18 claims
- 3576US7501407B2Pyrimidine A2B selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2004·Granted Mar 10, 2009·8 cites·7 claims
- 3676US7144711B2AGS proteins and nucleic acid molecules and uses thereforOSI PHARM INC·Filed 2004·Granted Dec 5, 2006·5 cites·15 claims
- 3775US6869944B2Method for treating a patient with neoplasia by treatment with a platinum coordination complexOSI PHARM INC·Filed 2002·Granted Mar 22, 2005·3 cites·3 claims
- 3875US6203976B1Methods of preparing compositions comprising chemicals capable of transcriptional modulationOSI PHARM INC·Filed 1994·Granted Mar 20, 2001·31 cites·26 claims
- 3974US7521448B2N-substituted benzimidazolyl c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Apr 21, 2009·9 cites·6 claims
- 4073US7645754B2Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2007·Granted Jan 12, 2010·1 cites·10 claims
- 4173US7598252B2Compounds specific to adenosine A, receptors and uses thereofOSI PHARM INC·Filed 2003·Granted Oct 6, 2009·4 cites·6 claims
- 4273US7566721B2Substituted thienol[2,3-d]pyrimidines as kinase inhibitorsOSI PHARM INC·Filed 2006·Granted Jul 28, 2009·3 cites·11 claims
- 4373US6706721B1N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrateOSI PHARM INC·Filed 1999·Granted Mar 16, 2004·13 cites·12 claims
- 4472US7388012B2(Hydrazido)(amino)thiophene compoundsOSI PHARM INC·Filed 2005·Granted Jun 17, 2008·1 cites·14 claims
- 4570US7521456B2N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrateOSI PHARM INC·Filed 2003·Granted Apr 21, 2009·3 cites·13 claims
- 4669US6686366B1Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 1999·Granted Feb 3, 2004·32 cites·50 claims
- 4767US7662844B2Naphthylene derivatives as cytochrome P450 inhibitorsOSI PHARM INC·Filed 2004·Granted Feb 16, 2010·6 cites·33 claims
- 4867US7064122B2Pancreatic lipase inhibitor compounds, their synthesis and useOSI PHARM INC·Filed 2002·Granted Jun 20, 2006·3 cites·27 claims
- 4967US6733991B1AGS proteins and nucleic acid molecules and uses thereforOSI PHARM INC·Filed 2000·Granted May 11, 2004·1 cites·13 claims
- 5065US6689381B2Liposomal benzoquinazoline thymidylate synthase inhibitor formulationsOSI PHARM INC·Filed 2001·Granted Feb 10, 2004·4 cites·67 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when OSI PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →